India: Law, Morality, Ethics And Religion-Biological Patents


From ages human beings have been trying to master the art of Biotechnology, but the 21st century has been seeing something different. The work in the field of Biotechnology has seen a rapid growth and this rapid growth and fierce competition have pushed the limits of intellectual rights and patent laws. With the advancement of technology and research more and more efforts are being put to patent life forms, organisms and Human parts in specific. This is an area which involves not only technology, Law, ethics and morality but also religion. Involvement of religious beliefs and practices around the world and the question of morality many a times lead to controversies and law suits.

Change in the basic nature of Humanity, conception of pseudo-human life forms and negativity associated with Humans "Playing God" are undoubtedly a cause of apprehension are real and a very problematic issue. This needs to be addressed with each and every improvement in the field of Biotechnology and assertion of patent rights on resulting innovation.


Thomas Jefferson the man behind the first Patent Act did not have even slightest idea that the life forms can ever become a subject of Patent protection. The most famous case of Diamond v Anand Chakrabarty where a biochemist at GE developed a genetically modified organism that had the ability to decompose crude oil. At first his patent application was rejected which on further appeal was granted by the court with order stating "His claim is not to a hitherto unknown natural phenomenon, but to a nonnaturally occurring manufacture or composition of matter-a product of human ingenuity".


Patent Act in India was enacted in 1856 from then it has been modified several times, one such major amendment was done in 1970 which satisfied the international norms of patentability such as Novelty, Inventive step and industrial application. The patent act 1970 had nothing specific concerning the Biotechnology invention and protection. At the same time patent offices and courts in US and EU were seeing increasing number of biotech inventions and patent application, as a result demand of amendment of Indian patent act to introduce biotech patentability gained significance in India. The amendment came in 2002 to explicitly include biochemical, biotechnological and microbiological processes within the definition of potentially patentable process.


The practices prevalent in India in this regard, and are quite nascent and the Topic of Biotechnology Patent is not as clear and tidy as it is in other fields of intellectual property. There are several outstanding deficiencies within the substantive law that needs addressing. Apart from narrow standards of patentability, biotech products are faced with certain additional hurdles like mandatory disclosure of biological material, prior approval from the Biodiversity Board and access & benefit issues under the Indian Patent regime.

The Indian Patents Act does not define, in an comprehensive manner, what is patentable. Relatively, Section 3 includes a list of inventions considered not patentable. In respect of biotechnology inventions, the Indian Patents Act 1970 as amended till date postulates under Section 3(a) to 3(e), 3(h) to 3(j) and 3(p), inventions that will not be considered as a patentable subject matter in India. Though, Clauses 3(c) to 3(d), 3(i) to 3(j) and 3(p) are imperative in the context of patentability of biotechnological inventions. Clause 3(c) states that "The mere discovery of a scientific principle or the formulation of an abstract theory or discovery of any living thing or nonliving substances occurring in nature" will not be considered as patentable invention.

This provision of non-patentability is common to patent laws of other countries. The Clause 3(j) states that "Plants and animals in whole or any part thereof other than microorganisms including seeds, varieties and species and essential biological processes for production or propagation of plants and animals as non-patentable invention".


  • Section 3 (b) - . As per the section an invention
  • would not be patentable if it is immoral or against public order, harmful to human, animal or plant life or harmful to environment
  • Discovery of living things or non living substances in nature - Section 3 (c)
  • Plants and animals in whole or any parts thereof other than micro-organisms but including seeds, varieties and species - Section 3 (j)
  • Essentially biological processes for the production or propagation of plants and animals– Section 3 (j)
  • Any Process for the medicinal, surgical, curative, prophylactic, diagnostic or therapeutic or other treatment of human beings or animals to render them free of disease or to increase their economic value or that of their products – Section 3(i)
  • Methods of agriculture or horticulture – Section 3(h)
  • Traditional knowledge – Section 3(p)1


  • The MPPP regards claims to 'genetically modified Gene Sequence/Amino Acid Sequence, a method of expressing the sequence, an antibody against the protein/ sequence, a kit containing such antibody/ sequence as having a single inventive concept and capable of being granted a patent
  • Gene sequences, DNA sequences without having disclosed their functions are not patentable for lack of inventive step and industrial application
  • Living entities of artificial origin such as microorganism, vaccines are patentable
  • Biological material such as rDNA, plasmids are patentable provided they are produced by substantive human intervention
  • Processes for producing chemical and biological substances using microorganisms including lower plants and animals are patentable
  • Modified Microorganism & process therefor
  • Process for modification/ isolation of microbes.
  • Isolated nucleic acids encoding gene, first time isolation of a molecule; novel peptides, novel peptide analogs, proteins, vaccines, antibodies, recombinant: DNA, RNA, Amino Acids, antibodies, primers, recombinant oligonucleotides and primers, genes and process therefor; DNA related inventions such as preparing plasmids, vectors etc.; composition/formulation thereof.
  • Cell lines-A cell line is patentable if artificially produced.
  • Hybridoma technology: patents are also allowed on hybridoma technology, but not on protoplast fusion.
  • rDNA, cDNA, r-RNA, r-antibodies
    • Expressed sequence tag's, or ESTs, are small fragments of genetic material
    • obtained by reverse transcriptions of messenger RNA (mRNA) from expressed
    • Genes. The gene sequence, or expressed sequence tags (ESTs), can be Patented if it
    • has a use, such as if it works as a probe.2


It can be seen that the Biotechnology and life form patentability is a subject of exploration in India. With more and more research and innovation going around in this field and keeping in view the rich Bio-Diversity that India enjoy, there is a true need to protect the interest of inventors. India needs to enable its inventors and inventions to compete in the global scenario, although few claims are do considered but they are more case to case basis and there is a lack of tidy guidelines.


1. Indian Patent act ,1970

2. Biotechnology Patenting In India and Related Issues - Rajashree Sharma

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Khurana and Khurana
Singh & Associates
Vaish Associates Advocates
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Khurana and Khurana
Singh & Associates
Vaish Associates Advocates
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions